WeVote
Log In

Bill

RB

Bill

A 4391

Allows pharmacists to transfer Schedule II attention-deficit/hyperactivity disorder prescriptions.

2024-2025 Regular Session Introduced by Rosy Bagolie and 9 co-sponsors

New Jersey permits pharmacists to transfer Schedule II ADHD prescriptions between providers, reducing medication gaps while raising diversion and prescriber oversight concerns.

Substituted by S3388
#pharmaceutic
0
WeVote Research Nonpartisan
Bill Summary · A 4391

Legislative bill overview

Assembly Bill A4391 permits licensed pharmacists in New Jersey to transfer Schedule II ADHD medication prescriptions between patients' healthcare providers without requiring a new prescription from the original prescriber. This expands pharmacists' clinical authority in medication management for controlled substances, a category typically restricted due to abuse potential.

Why is this important

ADHD medication interruptions can significantly disrupt treatment effectiveness and patient outcomes, particularly for children and working adults. This measure aims to reduce gaps in care caused by prescription processing delays, provider unavailability, or administrative barriers, while maintaining prescriber oversight since transfers still require physician authorization through existing prescription records.

Potential points of contention

  • Controlled substance diversion concerns: Schedule II drugs carry high abuse potential; expanding transfer authority increases handling points and could create opportunities for diversion, despite pharmacist licensing requirements and existing safeguards.
  • Prescriber autonomy and liability: Physicians may resist reduced control over controlled substance dispensing; unclear liability allocation if adverse outcomes occur during transferred prescriptions could create legal friction.
  • Implementation clarity: The bill may lack specific protocols defining what constitutes valid "transfer" authorization, which pharmacist credentials are required, documentation standards, and DEA compliance mechanisms—creating enforcement ambiguity.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.